Back to the main directory
EarningsReview / Equity
- The rerate wait is over (and 15 qs) by BNP Paribas Exane
- Risk and Business Analytics: faster for longer by BNP Paribas Exane
- Autoliv (Buy, TP: SEK910.00) - ZF recall could have significant positive impact on Autoliv by DnB Markets
- Storebrand (Buy, TP: NOK106.00) - Life is good by DnB Markets
- Rebalanced for rebound by BNP Paribas Exane
- Sharpen your pencils by BNP Paribas Exane
- GN Store Nord - GN going for glory by Danske Bank Equity Research
- Bang & Olufsen - Strong start to 2021/22 – across all lines by Danske Bank Equity Research
- INVEST SECURITIES - DEINOVE : Restructuration efficace en attendant dnv3837 - ACHAT, OC 1,20€ (vs 1,19€) by Invest Securities
- ESG Feedback from Saint-Gobain’s CMD: focus on moving to sustainable model maintained by Oddo BHF
- Investment Daily 07/10/2021 by BNP Paribas Exane
- Oasmia Pharmaceutical - Focused on pillars of growth by Edison Investment Research
- Standard Life UK Smaller Companies - Success from delivering ‘what it says on the tin’ by Edison Investment Research
- Cost inflation and competition by BNP Paribas Exane
- Better value elsewhere by BNP Paribas Exane
- Difficult to be more positive by BNP Paribas Exane
- Your freight is sealed by BNP Paribas Exane
- Sequana Medical - FDA clears expansion of POSEIDON enrolment by Edison Investment Research
- GN Group (Buy, TP: DKK555.00) - GN could have justified DKK9.3bn by DnB Markets
- Aker ASA (Buy, TP: NOK870.00) - Value in disguise by DnB Markets
- Pareto Bank (Buy, TP: NOK62.00) - Continued profitability by DnB Markets
- Itaú BBA on Camil: 2Q21 – Still Solid Rice Volumes, Weak International Operation by Itau
- Quarter Pounder by BNP Paribas Exane
- CMD: Growth and margin expansion beyond expectations by BNP Paribas Exane
- Strong demand with price hikes, but cost headwinds by BNP Paribas Exane